Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Innosurge Hips & Knees ApS
APS
In liquidation
CVR 38775219
Alsikevej 16
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2017
2 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2019
DKK 761K
+4420% vs 2018
EBITDA margin
38.6%
+187% vs 2018
Equity ratio
2.8%
Financial strength
Net profit 2019
DKK 288K
+185% vs 2018
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2018
0M
0%
2019
Key figures
Annual report 2019
Revenue
DKK 761K
+4420%
EBITDA
DKK 293K
+187%
Net profit
DKK 288K
+185%
Total assets
DKK 39K
-98%
Equity
DKK 1K
+100%
Employees
2
—
Company information
Legal name
Innosurge Hips & Knees ApS
CVR number
38775219
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
6. juli 2017
Share capital
DKK 50.000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Contact
Address
Alsikevej 16
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Randers
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2018
1M
2019
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
Income statement
DKK thousands
Item
2018
2019
Revenue
17
761
Staff expenses
-353
-468
EBITDA
-336
293
Depreciation & amort.
-0
-17
EBIT
-336
276
Net financials
-1
-27
Profit before tax
-337
249
Tax
-0
-39
Net profit
-337
288
Balance sheet
DKK thousands
Item
2018
2019
Total assets
1.785
39
Equity
-287
1
Long-term debt
0
0
Short-term debt
2.072
38
Total debt
2.072
38
Financial ratios
5-year trend
EBITDA margin
38.6%
This company
15.8%
Market median
+144% vs market
2018
2019
Equity ratio
2.8%
This company
38.2%
Market median
-93% vs market
2018
2019
Return on equity
26221.7%
This company
18.4%
Market median
+142409% vs market
2018
2019
Net profit margin
37.9%
This company
8.1%
Market median
+368% vs market
2018
2019
Asset turnover
19.72×
This company
1.12×
Market median
+1661% vs market
2018
2019
Debt / equity
34.12×
This company
0.62×
Market median
-5403% vs market
2018
2019
Annual reports & filings
Annual report 2019
Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via CVR / Virk · Period 2017-07-06 – 2018-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (3)
HK
Heinz Kvottrup Lorentzen
Chief Executive Officer
Chief Executive Officer
2017 – 2017
PM
Peter Møller Lassen
Chief Executive Officer
Chief Executive Officer
2017 – 2020
CB
Christian Beck Asmussen
Unofficial title
Unofficial title
2020 – 2020
Board of directors
Non-executive oversight
Name
Role
Member since
Former (2)
SA
Svend Aage Jensen
Board of Directors
2017 – 2020
MM
Michael Maigaard Nielsen
Chairman
2017 – 2020
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Helle Gert Gebuhr
Individual
20–24.99%
20–24.99%
2017
CMA HOLDING RANDERS ApS
Company
33.33–49.99%
33.33–49.99%
2018
Hy5 Holding IVS
Company
33.33–49.99%
33.33–49.99%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Innosurge Hips & Knees ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Heinz Kvottrup Lorentzen
Chief Executive Officer
0 companies
Peter Møller Lassen
Chief Executive Officer
0 companies
Christian Beck Asmussen
Unofficial title
0 companies
Svend Aage Jensen
Board of Directors
0 companies
Michael Maigaard Nielsen
Chairman
0 companies